GlassScriptPhysician profile
Drew Anne Morgan
NPI 1679129639
$10,804.26
in general payments reported to CMS, 2019-2025
40 companies · $19.24 in 2025
The $19.24 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,223 · 2022: $1,476 · 2023: $2,119 · 2024: $4,967 · 2025: $19.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,396 · Consulting Fee: $2,875 · Travel and Lodging: $809 · Education: $25.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,395.57 |
| Consulting Fee | $2,875.00 |
| Travel and Lodging | $808.72 |
| Education | $25.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $4,261.30 | 2023-2024 | Lumryz |
| Neurelis, INC. | $1,038.26 | 2021-2024 | Valtoco |
| Jazz Pharmaceuticals INC. | $477.10 | 2021-2024 | |
| Tris Pharma INC | $432.07 | 2022-2023 | Dyanavel Xr, Quillivant, Quillichew Er |
| Ucb, INC. | $394.26 | 2021-2024 | Briviact, Fintepla, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $371.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $356.35 | 2021 | |
| Livanova USA, INC. | $303.03 | 2021-2024 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Harmony Biosciences LLC | $244.37 | 2022-2024 | Wakix |
| Sk Life Science, INC. | $211.83 | 2021-2023 | |
| Idorsia Pharmaceuticals US INC | $200.91 | 2022-2023 | Quviviq |
| Sumitomo Pharma America, INC. | $193.37 | 2023-2024 | Aptiom |
| Abbvie INC. | $181.40 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $178.93 | 2021-2022 | |
| Neos Therapeutics, LP | $176.26 | 2023-2024 | Adzenys Xr-Odt |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.